85367-02-8

Basic information

• Product Name: 3-amino-N-pyridin-2-ylbenzamide
• Synonyms: 3-amino-N-pyridin-2-ylbenzamide
• CAS NO: 85367-02-8
• Molecular Formula: C₁₂H₁₁N₃O
• Molecular Weight: 213.23524
• Mol File: 85367-02-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-amino-N-pyridin-2-ylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-amino-N-pyridin-2-ylbenzamide(85367-02-8)
• EPA Substance Registry System: 3-amino-N-pyridin-2-ylbenzamide(85367-02-8)

Safety Data

• Hazardous Substances Data: 85367-02-8(Hazardous Substances Data)

Upstream product

• 504-29-0 2-aminopyridine 
• 121-90-4 m-nitrobenzoic acid chloride 
• 85367-01-7 3-nitro-N-(pyridin-2-yl)benzamide 

Downstream Products

• 608523-69-9 6-[3-(2-Pyridylcarbamoyl)phenylazo]-pyridoxal-5-phosphate 
• 90234-15-4 C₁₄H₁₆N₄O₃S 

Relevant articles and documents

AMINONAPTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES

The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseas

Synthesis and Antiviral Activity of Sulfonamidobenzophenone Oximes and Sulfonamidobenzamides

To find antiviral agents, various sulfonamidobenzophenone oximes (II) were synthesized from the appropriate m-sulfonamidobenzophenones by hydroxylamine reaction.The reaction products were generally obtained as syn/anti mixtures which were separable by fractional crystallization.The anti isomer had more potent antipoliovirus activity than the syn isomer.Various sulfonamidobenzamides (III) which were structurally related to II were synthesized by the reaction of amino-substituted benzamides with sulfuryl chloride or amines with (aminosulfonyl)benzoyl chloride.Antiviral activity was examined by the plaque-inhibition test.Compounds 5, 36, and 69 exhibited strong antipicornavirus activity.The structure-activity relationships are discussed.